Richard S. Lindahl - 15 Oct 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ Jessica Perl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
15 Oct 2025
Net transactions value
-$47,952
Form type
4
Filing time
17 Oct 2025, 16:02:38 UTC
Previous filing
10 Jun 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LINDAHL RICHARD S EVP, Chief Financial Officer 300 PROFESSIONAL DRIVE, GAITHERSBURG /s/ Jessica Perl, Attorney-in-fact 17 Oct 2025 0001196632

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $47,952 -4,995 -1.7% $9.60 291,497 15 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.